Viewing Study NCT01786395


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2025-12-27 @ 9:34 PM
Study NCT ID: NCT01786395
Status: TERMINATED
Last Update Posted: 2016-01-29
First Post: 2013-01-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Sponsor: R-Tech Ueno, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module